Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.3450 (-4.3%) ($4.9700 - $5.5400) on Thu. May. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.92% (three month average) | RSI | 76 | Latest Price | $5.3450(-4.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1% a day on average for past five trading days. | Weekly Trend | BCRX advances 15.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) IFRA(9%) IWC(9%) IWM(9%) IWN(9%) PAVE(9%) | Factors Impacting BCRX price | BCRX will decline at least -4.96% in a week (0% probabilities). IGOV(-6%) TLT(-3%) VIXM(-2%) UUP(-2%) INDA(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.96% (StdDev 9.92%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.25(1.81%) | 10 Day Moving Average | $5.19(2.99%) | 20 Day Moving Average | $4.49(19.04%) | To recent high | -4.3% | To recent low | 5.3% | Market Cap | $943m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |